Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Alpk2 | Rat | (-)-demecolcine | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of ALPK2 mRNA | CTD | PMID:23649840 | Alpk2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ALPK2 mRNA | CTD | PMID:22079256 | Alpk2 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | o and p'-DDT results in decreased expression of ALPK2 mRNA | CTD | PMID:18204070 | Alpk2 | Rat | 1,2-dichloroethane | decreases expression | ISO | Alpk2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of ALPK2 mRNA | CTD | PMID:28960355 | Alpk2 | Rat | 17beta-estradiol | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of ALPK2 mRNA | CTD | PMID:20106945 | Alpk2 | Rat | 17beta-estradiol | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of ALPK2 mRNA | CTD | PMID:30165855 | Alpk2 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ALPK2 mRNA | CTD | PMID:26496021 | Alpk2 | Rat | 17beta-estradiol | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of ALPK2 mRNA | CTD | PMID:21632981 | Alpk2 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of ALPK2 mRNA | CTD | PMID:29581250 | Alpk2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | Alpk2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ALPK2 mRNA | CTD | PMID:20106945 and PMID:21632981 | Alpk2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ALPK2 mRNA | CTD | PMID:33387578 | Alpk2 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:26705709 | Alpk2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Alpk2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ALPK2 mRNA | CTD | PMID:30951980 | Alpk2 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Alpk2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of ALPK2 gene | CTD | PMID:31683443 | Alpk2 | Rat | 4,4'-sulfonyldiphenol | increases methylation | ISO | ALPK2 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of ALPK2 gene | CTD | PMID:31601247 | Alpk2 | Rat | aflatoxin B1 | increases methylation | ISO | ALPK2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of ALPK2 gene | CTD | PMID:27153756 | Alpk2 | Rat | all-trans-retinoic acid | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of ALPK2 mRNA | CTD | PMID:21934132 | Alpk2 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ALPK2 mRNA | CTD | PMID:35163327 | Alpk2 | Rat | alpha-Zearalanol | decreases expression | EXP | | 6480464 | Zeranol results in decreased expression of ALPK2 mRNA | CTD | PMID:35163327 | Alpk2 | Rat | aristolochic acid A | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ALPK2 mRNA | CTD | PMID:33212167 | Alpk2 | Rat | arsenous acid | decreases expression | ISO | Alpk2 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of ALPK2 mRNA | CTD | PMID:35676786 | Alpk2 | Rat | benzo[a]pyrene | increases mutagenesis | ISO | ALPK2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of ALPK2 gene | CTD | PMID:25435355 | Alpk2 | Rat | benzo[a]pyrene | affects methylation | ISO | ALPK2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ALPK2 intron and Benzo(a)pyrene affects the methylation of ALPK2 promoter | CTD | PMID:27901495 and PMID:30157460 | Alpk2 | Rat | benzo[a]pyrene | decreases methylation | ISO | Alpk2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of ALPK2 intron | CTD | PMID:27901495 | Alpk2 | Rat | benzo[a]pyrene | increases methylation | ISO | ALPK2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ALPK2 exon | CTD | PMID:27901495 | Alpk2 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of ALPK2 mRNA | CTD | PMID:31163220 | Alpk2 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ALPK2 mRNA | CTD | PMID:26496021 | Alpk2 | Rat | bisphenol A | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of ALPK2 gene | CTD | PMID:31601247 | Alpk2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ALPK2 mRNA | CTD | PMID:25181051 | Alpk2 | Rat | bisphenol F | increases expression | ISO | Alpk2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of ALPK2 mRNA | CTD | PMID:30951980 | Alpk2 | Rat | bisphenol F | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of ALPK2 gene | CTD | PMID:31601247 | Alpk2 | Rat | bisphenol F | decreases methylation | ISO | ALPK2 (Homo sapiens) | 6480464 | bisphenol F results in decreased methylation of ALPK2 gene | CTD | PMID:31601247 | Alpk2 | Rat | butanal | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of ALPK2 mRNA | CTD | PMID:26079696 | Alpk2 | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ALPK2 mRNA | CTD | PMID:33453195 | Alpk2 | Rat | calcitriol | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of ALPK2 mRNA | CTD | PMID:21592394 | Alpk2 | Rat | calcitriol | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ALPK2 mRNA | CTD | PMID:21592394 | Alpk2 | Rat | CGP 52608 | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ALPK2 gene] | CTD | PMID:28238834 | Alpk2 | Rat | chromium(6+) | affects expression | ISO | Alpk2 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of ALPK2 mRNA | CTD | PMID:24374135 | Alpk2 | Rat | cisplatin | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ALPK2 mRNA | CTD | PMID:27392435 | Alpk2 | Rat | cisplatin | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of ALPK2 mRNA | CTD | PMID:27392435 | Alpk2 | Rat | cobalt atom | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [tungsten carbide co-treated with Cobalt] results in decreased expression of ALPK2 mRNA | CTD | PMID:18078969 | Alpk2 | Rat | copper(II) sulfate | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of ALPK2 mRNA | CTD | PMID:19549813 | Alpk2 | Rat | CU-O LINKAGE | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of ALPK2 mRNA | CTD | PMID:22077320 | Alpk2 | Rat | cyclosporin A | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ALPK2 mRNA | CTD | PMID:25562108 and PMID:27989131 | Alpk2 | Rat | cyclosporin A | increases methylation | ISO | ALPK2 (Homo sapiens) | 6480464 | Cyclosporine results in increased methylation of ALPK2 promoter | CTD | PMID:27989131 | Alpk2 | Rat | cyclosporin A | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ALPK2 mRNA | CTD | PMID:20106945 more ... | Alpk2 | Rat | cytarabine | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Cytarabine results in decreased expression of ALPK2 mRNA | CTD | PMID:21198554 | Alpk2 | Rat | deoxynivalenol | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of ALPK2 mRNA | CTD | PMID:31863870 | Alpk2 | Rat | dexamethasone | increases expression | ISO | Alpk2 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of ALPK2 mRNA | CTD | PMID:22733784 | Alpk2 | Rat | diarsenic trioxide | decreases expression | ISO | Alpk2 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of ALPK2 mRNA | CTD | PMID:35676786 | Alpk2 | Rat | dichloroacetic acid | decreases expression | ISO | Alpk2 (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of ALPK2 mRNA | CTD | PMID:28962523 | Alpk2 | Rat | dorsomorphin | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Alpk2 | Rat | doxorubicin | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ALPK2 mRNA | CTD | PMID:29803840 | Alpk2 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of ALPK2 mRNA | CTD | PMID:29391264 | Alpk2 | Rat | enzalutamide | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | enzalutamide results in decreased expression of ALPK2 mRNA | CTD | PMID:29581250 | Alpk2 | Rat | fenofibrate | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Fenofibrate results in increased expression of ALPK2 mRNA | CTD | PMID:25572481 | Alpk2 | Rat | formaldehyde | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of ALPK2 mRNA | CTD | PMID:23649840 | Alpk2 | Rat | fulvestrant | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of ALPK2 gene and [bisphenol F co-treated with Fulvestrant] results in decreased methylation of ALPK2 gene | CTD | PMID:31601247 | Alpk2 | Rat | genistein | decreases expression | ISO | Alpk2 (Mus musculus) | 6480464 | Genistein results in decreased expression of ALPK2 mRNA | CTD | PMID:32186404 | Alpk2 | Rat | isoprenaline | increases expression | ISO | Alpk2 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of ALPK2 mRNA | CTD | PMID:20003209 | Alpk2 | Rat | levonorgestrel | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ALPK2 mRNA | CTD | PMID:19074003 | Alpk2 | Rat | mercury dibromide | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of ALPK2 mRNA | CTD | PMID:26272509 | Alpk2 | Rat | mercury dibromide | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALPK2 mRNA | CTD | PMID:27188386 | Alpk2 | Rat | methylmercury chloride | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of ALPK2 mRNA | CTD | PMID:28001369 | Alpk2 | Rat | nickel sulfate | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of ALPK2 mRNA | CTD | PMID:22714537 | Alpk2 | Rat | O-methyleugenol | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of ALPK2 mRNA | CTD | PMID:32234424 | Alpk2 | Rat | paracetamol | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ALPK2 mRNA | CTD | PMID:29067470 | Alpk2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ALPK2 mRNA | CTD | PMID:30723492 | Alpk2 | Rat | perfluorononanoic acid | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of ALPK2 mRNA | CTD | PMID:32588087 | Alpk2 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of ALPK2 mRNA | CTD | PMID:32588087 | Alpk2 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ALPK2 mRNA | CTD | PMID:35163327 | Alpk2 | Rat | perfluorooctanoic acid | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of ALPK2 mRNA | CTD | PMID:32588087 and PMID:36326898 | Alpk2 | Rat | phenylmercury acetate | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of ALPK2 mRNA | CTD | PMID:26272509 | Alpk2 | Rat | phenylmercury acetate | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALPK2 mRNA | CTD | PMID:27188386 | Alpk2 | Rat | potassium chromate | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of ALPK2 mRNA | CTD | PMID:22079256 | Alpk2 | Rat | potassium chromate | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ALPK2 mRNA | CTD | PMID:22079256 | Alpk2 | Rat | potassium dichromate | decreases expression | ISO | Alpk2 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of ALPK2 mRNA | CTD | PMID:23608068 | Alpk2 | Rat | quercetin | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ALPK2 mRNA | CTD | PMID:21632981 | Alpk2 | Rat | SB 431542 | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Alpk2 | Rat | serpentine asbestos | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Asbestos and Serpentine results in decreased expression of ALPK2 mRNA | CTD | PMID:29523930 | Alpk2 | Rat | silicon dioxide | increases expression | ISO | Alpk2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of ALPK2 mRNA | CTD | PMID:29341224 | Alpk2 | Rat | sodium arsenite | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ALPK2 mRNA | CTD | PMID:22714537 and PMID:29301061 | Alpk2 | Rat | sodium arsenite | decreases expression | ISO | Alpk2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of ALPK2 mRNA | CTD | PMID:37682722 | Alpk2 | Rat | temozolomide | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of ALPK2 mRNA | CTD | PMID:31758290 | Alpk2 | Rat | testosterone | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ALPK2 mRNA | CTD | PMID:21592394 | Alpk2 | Rat | testosterone | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Testosterone results in increased expression of ALPK2 mRNA | CTD | PMID:21592394 | Alpk2 | Rat | testosterone undecanoate | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ALPK2 mRNA | CTD | PMID:19074003 | Alpk2 | Rat | testosterone undecanoate | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | testosterone undecanoate results in increased expression of ALPK2 mRNA | CTD | PMID:19074003 | Alpk2 | Rat | triadimefon | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | triadimefon results in decreased expression of ALPK2 mRNA | CTD | PMID:26705709 | Alpk2 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of ALPK2 mRNA | CTD | PMID:33387578 | Alpk2 | Rat | trichostatin A | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ALPK2 mRNA | CTD | PMID:24935251 and PMID:26705709 | Alpk2 | Rat | Tungsten carbide | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [tungsten carbide co-treated with Cobalt] results in decreased expression of ALPK2 mRNA | CTD | PMID:18078969 | Alpk2 | Rat | urethane | decreases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ALPK2 mRNA | CTD | PMID:28818685 | Alpk2 | Rat | valproic acid | increases methylation | ISO | ALPK2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ALPK2 gene | CTD | PMID:29154799 | Alpk2 | Rat | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ALPK2 mRNA | CTD | PMID:35594946 | Alpk2 | Rat | valproic acid | multiple interactions | ISO | ALPK2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALPK2 mRNA | CTD | PMID:27188386 | Alpk2 | Rat | valproic acid | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ALPK2 mRNA | CTD | PMID:23179753 more ... | Alpk2 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of ALPK2 mRNA | CTD | PMID:23034163 | Alpk2 | Rat | vincristine | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | Vincristine results in increased expression of ALPK2 mRNA | CTD | PMID:23649840 | Alpk2 | Rat | zoledronic acid | increases expression | ISO | ALPK2 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of ALPK2 mRNA | CTD | PMID:24714768 | |